DOCSLIB.ORG

Workshop DNA Polymorphism and Detection of Genetic And

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Workshop DNA Polymorphism and Detection of Genetic And 19. HqPL et a1 1985 Progrm and abstracts, Soc Mag Res Med, Molecular genetics of the X-linked muscular dystrophies 4th annual meet ing, Lcndcn 20.Radda GK et a1 1984 Brit Med Bull 40: 155 21. Siesjo BK 1978 Brain energy metabol ism. Chichester, Wi ley KAY DAVIES, SARAH BALL, HUW DORKINS, 22. Tofts PS, Wray S 1985 J Physiol 359: 417 23. Yocnkin DP et al 1984 -I 16:581 SUSAN FORREST, SUSAN KENWRICK, 24. Wllkie DR 1983 Blochem Soc Trans 2: 244 ISABELLE LAVENIR, SUSAN McGLADE, TERRY SMITH AND LYNN WILSON Workshop Nufield Department of Clinical Medicine, John Radclzffe DNA Polymorphism and Detection of Genetic Hospital, Oxford OX3 9DU The wtatims for Duchenne wscular dystrophy (DMD) and Becker and Infectious Diseases wscular dystrophy (BW) have been localised to the srme region of the short arm of the humn X chrmsm at Xp21 by l lnkage DNA-Diagnosis of Hemoglobinopathias and analysis to bridging CNA mrkers (1,2,3). Linkage studies shau thzt the frequency of recmbinatlm between wrkers in this regicn in Thalassemias the families segregating for these disorders is high (4,5,6). Q7e marker in particular is deleted in both a patient suffering frar B'D, chronic granulcnatous disease and retinitis pigmentosa (7) JURGEN HORST and in a Patient suffering frcm MD and glycerol kinase deficien- cy (81. The former has a visible cytogenetic deletim. This marker Human Genetics Institute, University of Muenster, Muenster, is linked at approxlmtely lOcM frathe M locus <5,6). An ad- BRD ditimal marker cn the opposite side of the WD and BMD loci also within Xp21 Is linked at a similar genetic distance (9). Althmgh Hemoglobinopathias and thalassemias are the two major types these two markers together can nau be used for antenatal diagnosis of inherited disorders of hemoglobin in man. While the hemo- (lo), mly a few fan1 1ies can be helped. bre closely Iinked are globinopathias exhibit qualitative changes of the globin molecule, being Identified. the thalassemias result from an imbalance in a- and non-a-globin Strategies are nau being developed to isolate additlmal se- chain production. In recent years the structural features of the quences localised within these deletims (11). These approaches normal human globin genes as well as the molecular lesions in should eventually lead to the identificatlm of the mlecular several hemoglobinopathias and many forms of thalassemias have basis of M*D and BMD and permit the investlgatim of the observed been determined by the application of recombinant DNA technology. high wtatim rate and the degree of heterogeneity of the mtaticns While globin gene deletions are the predominant underlying at the CNA level. molecular defects in a-thalassemia ayndroms, the majority of REFERENCES hemoglobinopathias and B-thalassemias are due to point mutations 1. Kingston HM, Harper PS, Pearsm PL, Davies KE, Will lamsm R, within the respective globin gene regions. Page D 1983 Lccalisatim of the gene for Becker dystrophy. For diagnostic purposes the identification of mutant genes Lancet 2: 1200 in cellular DNA is theoretically possible because of the direct 2. Kingstm HM, Thms NST, Pearsm PL, Sarfarazl M, Harper PS or indirect specificity of restriction enzymes. A direct identi- 1983 Genetlc linkage between Becker mscular dystrophy and a fication of the defective gene can be made if the mutation polymorphic CNA sequence m the short arm of the X chrmsaw. changed an enzyme's cleavage site and thus changes the normal DNA J Med Genet 20: 255-258 restriction pattern. For example, the direct detection of the 3. Davles, KE 1985 Molecular genetics of the hlman X chramsane. sickle cell gene with restriction enzyme Mst I1 and the hemo- J Med Genet In press globin (Hb) M Milwaukee gene with Sst I have recently been des- 4. Davies, KE, Briand P, Imasescu, V, Imasescu G, Wi I1ianscn R, cribed (10,9,2,3,7). An indirect identification of chromosomes Brm C, Cavard C, Cathelineau L 1985 Gene for OTC: characteri- that carry a mutant gene relies on the presence of inherited DNA satim and linkage to Duchenne rmscular dystrophy. Nucl Acids sequence polymorphisms within the cellular genome, giving rise Res 13: 155-165 to variations in restriction sites. Examples of this indirect 5. Davies, KE, Speer A, Hermnn F, Spiegler AWJ, McGlade 5, diagnostic procedure are the identification of defective D-globin Hofker W, Brland P, Hanke, R, Schwartz M, Steinblcker V, genes, causing hemoglobinopathias (e.g. Hb Freiburg, Hb Koln, Szibor R, Komer H, SmrD, Pearsm PL, Catelle C 1985 Hm Hb Presbyterian (8,4,5) or P-thalassemias (1,B)). X chrmscme wrkers and Duchenne mscular dystrophy. Nucl Acids A third possibility to identify chromosomes carrying point Res 13: 3419-3426 mutations or small deletions relies on oligonucleotide mapping 6. Brm CS, Pearscn PL, Thms NST, Sarfarazl M, Harper PS, Shaw procedures that have successfully been applied for diagnosis of DJ 1985 Linkage analysis of a M.IA polmrphism proximal to the some hemoglobinopathias and thalassemias. Here genotype analysis Cuchenne and Becker mscular dystrophy loci m the short arm relies on the detection of normal homozygotes, heterozygotes and of the X chraooscme. J Med Genet 22: 179-181 defective homozygotes exhibiting the respective three sets of 7. Francke U, Ochs HD, De Martinvllle B, Giacalcne J, Lindgren V, intense, intermediate and missing band signals upon hybridization Disteche C, Pagm RA, Hofker M, Van Chmm GJB, Pearscn PL, with oligonucleotides complementary to the normal or the mutated Wedgwood RJ 1985 Minor Xp21 chrmsaw deleticn in a male asso- gene sequence. These experimental conditions can also be used in ciated with expressicn of Duchenne rmscular dystrophy, chrcnic diseases with an autosomal dominant inheritance pattern as in granulcmatous disease, ret In1t is plgmntosa, and McLeod syndrm. the Hb Freiburg disorder, where normal homozygotes can be differ- Pm J Hun Genet 37: 250-268 entiated from Hb Freiburg patients (Horst et al. unpublished). 8. Dunger DB, Davies KE, Pembrey ME, Lake BD, Pearsm PL, Willim All these methods have been applied for pre- and postnatal D, Whitfield T, Dillm MJD 1985 A deleticn m the X chrmsm diagnostic purposes. In genetic counselling they have been used detected by direct DNA analysls, in me of two unrelated boys together with chorion biopsy or amniocentesis to provide prenatal with glycerol kinase deficiency, adrenal hypopiasla and 'Du- diagnosis in families at risk. In the case of a-thalassemias chenne type' rmscular dystrophy. Submitted to N Engl J Med prenatal diagnosis might only be applied to permit a mother with 9. Dorklns HR, Old JM, Mandel J-1, Bmdey S, Schwartz M, Carpenter a fetus with hydrops fetalis to choose whether to carry the fetus NJ, Lindlof, M, De la Chapel le, A, Kmkel L, Pearsm PL, Davies through the full 9 month of pregnancy. However, together with KE 1985 Segregatlm analysis of a marker localised Xp21.2-Xp21.3 hematological and family studies DNA-analysis data are especially In Cuchenne and Becker mscular dystrophy families. HUT Genet useful to differentiate between a-thalassemla-1 and a-thalasse- in press mia-2 patients and thus to determine the exact diagnosis (6). 10. Bakker, E, Hofker M-I, Goorl N, Mandel JL, Davies KE, Kunkel LM. Wi 1lard HF, Fentm WA, Sandkuy l L, Majoor-krakauer D, Van Essen Refe- A, Jahoda M, Sachs ES, Van Omlen GJB, Pearscn PL 1985 Prenatal 1. PntcnaWis StE, Kazazirn H1, Orkin StH 1985, Km Geret 69: 1 diagnosis and carrier detectim of Duchenne mswular dystrophy 2. ChqX, Krn W 1982, N Em$ J kl 307: X) 3. tbrst J. Wfer R, Kleihaer E, Kdne E 1983, Brit J km 54: 643 with closely linked RFLPs. Lmcet 1: 655-658 11. LaMr EE, Palmer E 1984 Y-encoded, specles-specific DNA In mice: 4. turst J, Uehre R, Kle-r E, KdR E 1984, Blut 48: 213 5. brst J, Wm R, Klelkr E, K~YI? E 1983, Km ktW 263 evidence that the Y chraooscme exlsts in two polymsrphic forms 6. brst J, Griese EU, Kleihaer E, KdR E 1984, Hm ht68: 260 in Inbred strains. Cell 37: 171-177 of the wtatims at the 7. Wm R, K~TEE, Klelhaer E, tbrst J 1983, Hm kt64: 376 CNA level. 8. bR, Kdne E, brst J, shnitted for pblicatim 9. Drkin W, Little FfR, Kazazlan Hi Jr, Boehn a) 1582, N Er@ J M M7: 32 10. Kilsn JT, Mihr Ff, hr8, Mlleth FS, Fa&l K, Re~rrbllarl3l, Mh'w$ FG, Wilscn LB 19'82, Pnc Mtl Pcaj %l US4 79: 3628 .
Load more

Recommended publications
  • Endogenous Reverse Transcriptase and Rnase H-Mediated Antiviral Mechanism in Embryonic Stem Cells
    www.nature.com/cr www.cell-research.com ARTICLE Endogenous reverse transcriptase and RNase H-mediated antiviral mechanism in embryonic stem cells Junyu Wu1, Chunyan Wu1, Fan Xing1, Liu Cao1, Weijie Zeng1, Liping Guo1, Ping Li1, Yongheng Zhong1, Hualian Jiang1, Manhui Luo1, Guang Shi2, Lang Bu1, Yanxi Ji1, Panpan Hou1, Hong Peng1, Junjiu Huang2, Chunmei Li1 and Deyin Guo 1 Nucleic acid-based systems play important roles in antiviral defense, including CRISPR/Cas that adopts RNA-guided DNA cleavage to prevent DNA phage infection and RNA interference (RNAi) that employs RNA-guided RNA cleavage to defend against RNA virus infection. Here, we report a novel type of nucleic acid-based antiviral system that exists in mouse embryonic stem cells (mESCs), which suppresses RNA virus infection by DNA-mediated RNA cleavage. We found that the viral RNA of encephalomyocarditis virus can be reverse transcribed into complementary DNA (vcDNA) by the reverse transcriptase (RTase) encoded by endogenous retrovirus-like elements in mESCs. The vcDNA is negative-sense single-stranded and forms DNA/RNA hybrid with viral RNA. The viral RNA in the heteroduplex is subsequently destroyed by cellular RNase H1, leading to robust suppression of viral growth. Furthermore, either inhibition of the RTase activity or depletion of endogenous RNase H1 results in the promotion of virus proliferation. Altogether, our results provide intriguing insights into the antiviral mechanism of mESCs and the antiviral function of endogenized retroviruses and cellular RNase H. Such a natural nucleic acid-based antiviral mechanism in mESCs is referred to as ERASE (endogenous RTase/RNase H-mediated antiviral system), which is an addition to the previously known nucleic acid-based antiviral mechanisms including CRISPR/Cas in bacteria and RNAi in plants and invertebrates.
    [Show full text]
  • Restriction Endonucleases
    Molecular Biology Problem Solver: A Laboratory Guide. Edited by Alan S. Gerstein Copyright © 2001 by Wiley-Liss, Inc. ISBNs: 0-471-37972-7 (Paper); 0-471-22390-5 (Electronic) 9 Restriction Endonucleases Derek Robinson, Paul R. Walsh, and Joseph A. Bonventre Background Information . 226 Which Restriction Enzymes Are Commercially Available? . 226 Why Are Some Enzymes More Expensive Than Others? . 227 What Can You Do to Reduce the Cost of Working with Restriction Enzymes? . 228 If You Could Select among Several Restriction Enzymes for Your Application, What Criteria Should You Consider to Make the Most Appropriate Choice? . 229 What Are the General Properties of Restriction Endonucleases? . 232 What Insight Is Provided by a Restriction Enzyme’s Quality Control Data? . 233 How Stable Are Restriction Enzymes? . 236 How Stable Are Diluted Restriction Enzymes? . 236 Simple Digests . 236 How Should You Set up a Simple Restriction Digest? . 236 Is It Wise to Modify the Suggested Reaction Conditions? . 237 Complex Restriction Digestions . 239 How Can a Substrate Affect the Restriction Digest? . 239 Should You Alter the Reaction Volume and DNA Concentration? . 241 Double Digests: Simultaneous or Sequential? . 242 225 Genomic Digests . 244 When Preparing Genomic DNA for Southern Blotting, How Can You Determine If Complete Digestion Has Been Obtained? . 244 What Are Your Options If You Must Create Additional Rare or Unique Restriction Sites? . 247 Troubleshooting . 255 What Can Cause a Simple Restriction Digest to Fail? . 255 The Volume of Enzyme in the Vial Appears Very Low. Did Leakage Occur during Shipment? . 259 The Enzyme Shipment Sat on the Shipping Dock for Two Days.
    [Show full text]
  • Phosphodiesterase 1B Knock-Out Mice Exhibit Exaggerated Locomotor Hyperactivity and DARPP-32 Phosphorylation in Response to Dopa
    The Journal of Neuroscience, June 15, 2002, 22(12):5188–5197 Phosphodiesterase 1B Knock-Out Mice Exhibit Exaggerated Locomotor Hyperactivity and DARPP-32 Phosphorylation in Response to Dopamine Agonists and Display Impaired Spatial Learning Tracy M. Reed,1,3 David R. Repaske,2* Gretchen L. Snyder,4 Paul Greengard,4 and Charles V. Vorhees1* Divisions of 1Developmental Biology and 2Endocrinology, Children’s Hospital Research Foundation, Cincinnati, Ohio 45229, 3Department of Biology, College of Mount St. Joseph, Cincinnati, Ohio 45233, and 4Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, New York 10021 Using homologous recombination, we generated mice lack- maze spatial-learning deficits. These results indicate that en- ing phosphodiesterase-mediated (PDE1B) cyclic nucleotide- hancement of cyclic nucleotide signaling by inactivation of hydrolyzing activity. PDE1B Ϫ/Ϫ mice showed exaggerated PDE1B-mediated cyclic nucleotide hydrolysis plays a signifi- hyperactivity after acute D-methamphetamine administra- cant role in dopaminergic function through the DARPP-32 and tion. Striatal slices from PDE1B Ϫ/Ϫ mice exhibited increased related transduction pathways. levels of phospho-Thr 34 DARPP-32 and phospho-Ser 845 Key words: phosphodiesterases; DARPP-32; dopamine- GluR1 after dopamine D1 receptor agonist or forskolin stimu- stimulated locomotor activity; spatial learning and memory; lation. PDE1B Ϫ/Ϫ and PDE1B ϩ/Ϫ mice demonstrated Morris Morris water maze; methamphetamine; SKF81297; forskolin Calcium/calmodulin-dependent phosphodiesterases (CaM- (CaMKII) and calcineurin and have the potential to activate PDEs) are members of one of 11 families of PDEs (Soderling et CaM-PDEs. Dopamine D1 or D2 receptor activation leads to al., 1999;Yuasa et al., 2001) and comprise the only family that acts adenylyl cyclase activation or inhibition, respectively (Traficante ϩ as a potential point of interaction between the Ca 2 and cyclic et al., 1976; Monsma et al., 1990; Cunningham and Kelley, 1993; nucleotide signaling pathways.
    [Show full text]
  • Disruption of the Aldolase a Tetramer Into Catalytically Active Monomers PETER T
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 5374-5379, May 1996 Biochemistry Disruption of the aldolase A tetramer into catalytically active monomers PETER T. BEERNINK* AND DEAN R. TOLANt Biology Department, Boston University, Boston, MA 02215 Communicated by Irwin A. Rose, Fox Chase Cancer Center, Philadelphia, PA, January 22, 1996 (received for review August 30, 1995) ABSTRACT The fructose-1,6-bisphosphate aldolase (EC interface loop of TIM resulted in a stable monomer with a 4.1.2.13) homotetramer has been destabilized by site-directed 103-fold reduction in kcat (11, 12). These studies have suggested mutagenesis at the two different subunit interfaces. A double that the quaternary structure is essential for proper catalytic mutant aldolase, Q125D/E224A, sediments as two distinct activity. species, characteristic of a slow equilibrium, with velocities Fructose-1,6-bisphosphate aldolase (Fru-1,6-P2; EC 4.1.2.13) is expected for the monomer and tetramer. The aldolase mono- an isologous homotetramer (Fig. 1A), each subunit ofwhich is an mer is shown to be catalytically active following isolation from eight-membered acq-barrel containing an active site near its sucrose density gradients. The isolated aldolase monomer had center (13). The two major subunit interfaces (A and B) are 72% of the specific activity of the wild-type enzyme and a distant (>20 A) from the Schiff base-forming Lys-229 (Fig. iB), slightly lower Michaelis constant, clearly indicating that the and aldolase does not exhibit cooperativity or allostery. Isolated quaternary structure is not required for catalysis. Cross- hybrids of isozymes indicated that subunits are catalytically linking of the isolated monomer confirmed that it does not independent; for example, A3B1 was indistinguishable from an rapidly reequilibrate with the tetramer following isolation.
    [Show full text]
  • Directions for Use Shrimp Alkaline Phosphatase, Recombinant (Rsap)
    Directions for Use Shrimp Alkaline Phosphatase, Recombinant (rSAP) Code Description Size 1B1633-1KU Shrimp Alkaline Phosphatase, Recombinant (rSAP) 1 vial, 1000 units (1 U/µL) 1B1633-5KU Shrimp Alkaline Phosphatase, Recombinant (rSAP) 5 vials, 1000 units each (1 U/µL) General Information Shrimp Alkaline Phosphatase, Recombinant (rSAP) is a heat-labile hydrolase enzyme produced in Pichia Pastoris that removes phosphate groups nonspecifically from 5’ ends of nucleic acid phosphomonoesters and proteins. This activity is most commonly utilized in molecular cloning to prevent self-ligation of linearized plasmid DNA and in 5’ end-labeling to facilitate the replacement of unlabeled phosphates with labeled phosphate groups. rSAP also prepares PCR products for DNA sequencing or SNP analysis, by dephosphorylating unincorporated dNTPs that would otherwise interfere with enzymatic reactions. VWR Life Science AMRESCO’s rSAP may be directly added to restriction enzyme digests and is conveniently inactivated 100% by heating at 65°C. This eliminates the need for vector purification, a step that is necessary when using alkaline phosphatases isolated from other sources, such as E. coli and calf intestine. rSAP works well in common buffers and does not require supplemental zinc or other additives. Removes 5’-phosphates from DNA, RNA, dNTPs and proteins Improves cloning efficiency by preventing vector recircularization 100% heat-inactivated at 65°C No vector purification necessary Removes unincorporated dNTPs in PCR products prior to DNA sequencing or SNP analysis Prepares templates for 5’-end labeling Dephosphorylates proteins Works in many different buffers without supplemental factors AMRESCO, LLC Corporate Headquarters, 28600 Fountain Parkway, Solon, OH 44139 Directions for Use Storage/Stability Stable at least 2 years when stored frozen (0 to -20°C).
    [Show full text]
  • Rapid Alkaline Phosphatase
    For life science research only. Not for use in diagnostic procedures. rAPid Alkaline Phosphatase Orthophosphoric-monoester phosphohydrolase (alkaline optimum), EC 3.1.3.1 Cat. No. 04 898 133 001 1000 units Cat. No. 04 898 141 001 5000 units y Version 03 Content version : May 2019 Store at Ϫ15 to Ϫ25°C 1. What this Product Does Enzyme Characteristics Number of Tests Parameter Description 1 kit is designed for Source Recombinant alkaline phosphatase from bovine intes- • 1000 dephosphorylation reactions (Cat. No. 04 898 133 001) tine (1) expressed in Pichia pastoris • 5000 dephosphorylation reactions (Cat. No. 04 898 141 001) Molecular 56 kD (by SDS-PAGE, monomer) with a final reaction volume of 20 ␮l each. weight 2+ Pack Contents Subunits homodimer (Zn is essential for activity) Unit Definition One unit of rAPid Alkaline Phosphatase is the enzyme Label Contents / Function activity which hydrolyzes 1 ␮mol of 4-nitrophenyl rAPid Alkaline Phos- 0.5 M Tris/HCl, 1mM EDTA, pH 8.5 (20°C) phosphatase in 1 min at 37°C under assay conditions. phatase Buffer, Volume 1 U/␮l 10ϫ conc. Activity rAPid Alkaline Phos- • 1000 U (Cat. No. 04 898 133 001) Specific Approx. 1U/␮g according to (2) and (3). phatase • 5000 U (Cat. No. 04 898 141 001) Activity See data label for lot-specific values. Storage and Stability Specificity Alkaline Phosphatase catalyzes the hydrolysis of numerous phosphate esters, such as esters of primary Ϫ Ϫ If stored at 15 to 25°C the product is stable through the expiration and secondary alcohols, saccharides, cyclic alcohols, date printed on the label.
    [Show full text]
  • Clinical and Molecular Characterization of Patients with Fructose 1,6-Bisphosphatase Deficiency
    Article Clinical and Molecular Characterization of Patients with Fructose 1,6-Bisphosphatase Deficiency Niu Li 1,†, Guoying Chang 2,†, Yufei Xu 1, Yu Ding 2, Guoqiang Li 1, Tingting Yu 1, Yanrong Qing 1, Juan Li 2, Yiping Shen 1,3, Jian Wang 1,* and Xiumin Wang 2,* 1 Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China; [email protected] (N.L.); [email protected] (Y.X.); [email protected] (G.L.); [email protected] (T.Y.); [email protected] (Y.Q.); [email protected] (Y.S.) 2 Department of Endocrinology and Metabolism, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China; [email protected] (G.C.); [email protected] (Y.D.); [email protected] (J.L.) 3 Department of Laboratory Medicine, Boston Children’s Hospital, Boston, MA 02115, USA * Correspondence: [email protected] (J.W.); [email protected] (X.W.); Tel.: +86-21-3862-6161 (J.W. & X.W.); Fax: +86-21-5875-6923 (J.W. & X.W.) † These authors contributed equally to this work. Academic Editor: William Chi-shing Cho Received: 26 February 2017; Accepted: 17 April 2017; Published: 18 April 2017 Abstract: Fructose-1,6-bisphosphatase (FBPase) deficiency is a rare, autosomal recessive inherited disease caused by the mutation of the FBP1 gene, the incidence is estimated to be between 1/350,000 and 1/900,000. The symptoms of affected individuals are non-specific and are easily confused with other metabolic disorders.
    [Show full text]
  • Restriction Digest
    PROTOCOL 3: RESTRICTION DIGEST TEACHER VERSION THE GENOME TEACHING GENERATION PROTOCOL 3: RESTRICTION DIGEST PROTOCOL 3: RESTRICTION DIGEST TEACHER VERSION PRE-REQUISITES & GOALS STUDENT PRE-REQUISITES Prior to implementing this lab, students should understand: • The central dogma of how DNA bases code for mRNA and then for proteins • How DNA samples were collected and prepared for PCR • The steps that occur during the process of polymerase change reaction (PCR) • What restriction enzymes are and how they work • How the sequence variants in OXTR and CYP2C19 are affected by restriction enzyme digestion • The purpose of PROTOCOL 3 is to determine genotype STUDENT LEARNING GOALS 1. Perform restriction digestion of PCR products of CYP2C19 and/or OXTR. 2. Describe the possible genotypes for individuals with the CYP2C19 and/or OXTR genes. 3. Predict what each genotype will look like after gel electrophoresis and why. 2 TEACHING THE GENOME GENERATION | THE JACKSON LABORATORY PROTOCOL 3: RESTRICTION DIGEST TEACHER VERSION CURRICULUM INTEGRATION Use the planning notes space provided to reflect on how this protocol will be integrated into your classroom. You’ll find every course is different, and you may need to make changes in your preparation or set-up depending on which course you are teaching. Course name: 1. What prior knowledge do the students need? 2. How much time will this lesson take? 3. What materials do I need to prepare in advance? 4. Will the students work independently, in pairs, or in small groups? 5. What might be challenge points
    [Show full text]
  • Faqs for DNA End Modification: Dephosphorylation
    FAQs for DNA End Modification: Dephosphorylation 1. Does the DNA need to be purified after a restriction digest and prior to the dephosphorylation step? If the enzymes used in the restriction digest are heat inactivatable, then a purification step is not needed. If the enzymes used are not heat-inactivatable, then a clean-up step between the restriction digest and the dephosphorylation step is recommended. 2. Does the DNA need to be purified after the dephosphorylation step and prior to the ligation step? If you use rSAP or Antarctic Phosphatase, which are heat-inactivatable, then a clean- up step is not necessary. If the alkaline phosphatase used is CIP, which is not heat- inactivatable, then a clean-up step is necessary. 3. Which alkaline phosphatase, CIP, Antarctic or rSAP, works best? rSAP (NEB #M0371) is a superior choice because it combines the advantages of both CIP (NEB #M0290) and Antarctic Phosphatase (NEB #M0289). rSAP has a very high specific activity comparable to CIP, but CIP cannot be completely heat-inactivated. rSAP is heat-inactivated in 5 minutes, as is Antarctic Phosphatase, but rSAP is preferred over Antarctic Phosphatase because it does not require added zinc or any other co-factors. As a result, rSAP can be added directly to restriction enzyme digests. Additionally, after heat-inactivation of rSAP, it is not necessary to purify vector DNA prior to the ligation reaction. 4. Are the alkaline phosphatases active in NEBuffers? rSAP: rSAP is active in all restriction enzyme NEBuffers 1.1, 2.1, 3.1 and CutSmart™ Buffer, and can be added directly to digested DNA.
    [Show full text]
  • Expanded Roles of the Fanconi Anemia Pathway in Preserving Genomic Stability
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Expanded roles of the Fanconi anemia pathway in preserving genomic stability Younghoon Kee and Alan D. D’Andrea1 Department of Radiation Oncology and Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA Studying rare human genetic diseases often leads to a gene products are believed to function in a common DNA better understanding of normal cellular functions. Fan- repair signaling pathway, the FA pathway, which closely coni anemia (FA), for example, has elucidated a novel cooperates with other DNA repair proteins for resolving DNA repair mechanism required for maintaining geno- DNA ICLs during replication (Fig. 1). A central event in mic stability and preventing cancer. The FA pathway, an the pathway is the monoubiquitination of FANCD2 and essential tumor-suppressive pathway, is required for pro- FANCI upon DNA damage, which is mediated by a group tecting the human genome from a specific type of DNA of upstream FA proteins (FANCA, FANCB, FANCC, damage; namely, DNA interstrand cross-links (ICLs). In FANCE, FANCF, FANCG, FANCL, and FANCM) that this review, we discuss the recent progress in the study are assembled into a large nuclear E3 ubiquitin ligase of the FA pathway, such as the identification of new complex, termed the ‘‘FA core complex’’ (Kennedy and FANCM-binding partners and the identification of D’Andrea 2005; Wang 2007). The monoubiquitinated RAD51C and FAN1 (Fanconi-associated nuclease 1) as FANCD2/FANCI heterodimer was shown to play multi- new FA pathway-related proteins.
    [Show full text]
  • Restriction Endonucleases
    Restriction Endonucleases TECHNICAL GUIDE UPDATE 2017/18 be INSPIRED drive DISCOVERY stay GENUINE RESTRICTION ENZYMES FROM NEB Cut Smarter with Restriction Enzymes from NEB® Looking to bring CONVENIENCE to your workflow? Simplify Reaction Setup and Double Activity of DNA Modifying Enzymes in CutSmart Buffer: Digestion with CutSmart® Buffer Clone Smarter! Activity Enzyme Required Supplements Over 210 restriction enzymes are 100% active in a single buffer, in CutSmart Phosphatases: CutSmart Buffer, making it significantly easier to set up your Alkaline Phosphatase (CIP) + + + double digest reactions. Since CutSmart Buffer includes BSA, there Antarctic Phosphatase + + + Requires Zn2+ Quick CIP + + + are fewer tubes and pipetting steps to worry about. Additionally, Shrimp Alkaline Phosphatase (rSAP) + + + many DNA modifying enzymes are 100% active in CutSmart Ligases: T4 DNA Ligase + + + Requires ATP Buffer, eliminating the need for subsequent purification. E. coli DNA Ligase + + + Requires NAD T3 DNA Ligase + + + Requires ATP + PEG For more information, visit www.NEBCutSmart.com T7 DNA Ligase + + + Requires ATP + PEG Polymerases: T4 DNA Polymerase + + + DNA Polymerase I, Large (Klenow) Frag. + + + DNA Polymerase I + + + DNA Polymerase Klenow Exo– + + + Bst DNA Polymerase + + + ™ phi29 DNA Polymerase + + + Speed up Digestions with Time-Saver T7 DNA Polymerase (unmodified) + + + Qualified Restriction Enzymes Transferases/Kinases: T4 Polynucleotide Kinase + + + Requires ATP + DTT T4 PNK (3´ phosphatase minus) + + + Requires ATP + DTT > 190 of our restriction enzymes are able to digest DNA in CpG Methyltransferase (M. SssI) + + + 5–15 minutes, and can safely be used overnight with no loss of GpC Methyltransferase (M. CviPI) + Requires DTT T4 Phage β-glucosyltransferase + + + sample. For added convenience and flexibility, most of these are Nucleases, other: supplied with CutSmart Buffer.
    [Show full text]
  • Nucleic Acids Research
    Volume 7 Number 1 1979 Nucleic Acids Research Site specific enzymatic cleavage of RNA Helen Donis-Keller Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, MA 02138, USA Received 11 July 1979 ABSTRACT The hybridization of a DNA oligonucleotide (a specific tetramer or longer) will direct a cleavage by RNase H (EC 3.1.4.34) to a specific site in RNA. The resulting fragments can then be labeled at their 5' or 3' ends, purified, and sequenced directly. This procedure is demonstrated with two RNA molecules of known sequence: 5.8S rRNA from yeast (158 nucleotides) and satellite tobacco necrosis virus (STNV) RNA (1240 nucleotides). INTRODUCTION Rapid, direct sequencing techniques exist for terminally labeled RNA molecules up to 200 nucleotides in length (1-6). However, the sequence de- termination of larger molecules still presents problems, since there are not methods to fragment RNA analogous to restriction endonuclease cleavage of DNA (7). Although one can isolate partial RNase cleavage products (8-10), it is laborious to prepare a sufficient quantity of large RNA fragments which can be ordered by sequence overlaps. This communication describes an enzymatic method which avoids this difficulty. The method relies on the ability of ribonuclease H, purified from E. coli (11-13) or calf thymus (14-16), to attack only RNA-DNA hybrids breaking the RNA endonucleolytically to produce a 3' hydroxyl and a 5' phosphate at the point of cleavage (11,12,14-18). RNase H does not hydrolyze RNA-RNA hybrids, single-stranded RNA or DNA, or DNA-DNA hybrids (11,12,14,15,17-20).
    [Show full text]